Crystal structure

   
   

A process for the production of crystals with controlled surface smoothness, size, shape and degree of crystallinity, compositions comprising such crystals, and the use of certain crystals, especially lactose, lactose monohydrate, fluticasone propionate, salmeterol xinafoate, salbutamol sulphate or ipratropium bromide in pharmaceutical compositions.

 
Web www.patentalert.com

< Method of intracellular sustained-release of drug and preparations

< Modulating a pharmacokinetic property of a drug by administering a bifunctional molecule containing the drug

> USE OF TRIAQUA-.mu.3-OXOHEXAKIS-.mu.-PROPIONATOTRICHROMIUM(1+), [CR3O(O2CCH2CH3)6(H2O)3]+, AS A NUTRITIONAL SUPPLEMENT OR IN TREATMENT OF MEDICAL CONDITIONS

> Chlamydia protein, gene sequence and uses thereof

~ 00171